地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:15172469628
传真:17754422825
邮箱:sales@amyjet.com
艾美捷科技有限公司代理Kingfisher Biotech公司产品,详见:
http://www.amyjet.com/Index/lists/catid/27/kid/51.html
Kingfisher Biotech致力于兽医学研究和人类疾病的动物模型,涵盖的物种包括:牛、狗、马、鸡、海豚、猫、猪、仓鼠、小鼠、兔子、大鼠、火鸡等等。目前,Kingfisher Biotech的产品线中有查过1200种重组蛋白、多抗、单抗和ELISA试剂盒,能够为全世界动物保健和动物模型客户提供优质的产品。
Kingfisher Biotech, Inc. is committed to accelerating basic veterinary research and human disease research done in animal models by developing and commercializing research reagents specific for a variety of species, including bovine, canine, caprine, chicken, dolphin, equine, feline, guinea pig, hamster, human, mouse, ovine, rabbit, rat, swine, and turkey. We will continue to add species as our customer request specific reagents for their research. Currently, we offer over 1200 recombinant proteins, polyclonal antibodies, monoclonal antibodies and ELISA kits for animal health and animal model research. Our products are primarily cytokines, chemokines, interferons, and growth factors.
Kingfisher Biotech公司产品涉及的物种包括:
Bovine、Canine、Caprine、Catfish、Chicken、Dolphin、Equine、Feline、Ferret、Guinea Pig、Hamster、Human、Llama、Monkey、Mouse、Ovine、Rabbit、Rat、Salmon、Swine、Turkey、Zebrafish
| 产品列表 |
| Anole IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1675A-025) |
| Anole IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1675A-005) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1676A-100) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1676A-025) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1676A-005) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1676A-500) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody (Kingfisher, CAT#KP1690Y-100) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1691Y-050) |
| Cynomolgus Monkey CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1692Y-003) |
| Bee Defensin-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1644AP-025) |
| Bee Defensin-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1644AP-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| Bovine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1319B-005) |
| Bovine/Caprine/Ovine IL-5 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0139B-025) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL3 (MIP-1 alpha) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1143B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Bovine CD40 Ligand Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1211B-003) |
| Bovine CXCL10 (IP-10) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0662B-003) |
| Bovine CXCL9 (MIG) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0661B-003) |
| Bovine Erythropoietin (EPO) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1585B-003) |
| Bovine IL-1 alpha (IL-1F1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0667B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-17A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0673B-003) |
| Bovine IL-2 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1100B-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Human APRIL (TNFSF13) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0292H-005) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1085H-100) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1085H-025) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1085H-005) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1085H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP01528H-025) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP01528H-005) |
| Human CCL21 (6Ckine) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1512H-005) |
| Human CCL7 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1531H-025) |
| Human CCL7 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1531H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1657GP-100) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1657GP-025) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1657GP-005) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1657GP-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0754D-100) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0754D-025) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0754D-005) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0754D-500) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0085D-100) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0085D-025) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0085D-005) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0085D-500) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0920D-100) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0920D-025) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0920D-005) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0920D-500) |
| Canine IL-25 (IL-17E) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1697D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1010D-100) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1010D-025) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1010D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1010D-500) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 100 microgrrams (Kingfisher, CAT#RP1322D-100) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 25 microgrrams (Kingfisher, CAT#RP1322D-025) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1322D-005) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP1322D-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Catfish IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0439CF-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP01528H-025) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP01528H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1672H-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody (Kingfisher, CAT#KP1690Y-100) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1691Y-050) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Llama ACT1 Activation Monoclonal Antibody (clone LH9A) (Kingfisher, CAT#WS0813L-100) |
| Llama B Cell Subpopulation Monoclonal Antibody (clone LH7A) (Kingfisher, CAT#WS0812L-100) |
| Llama B Cell Subpopulation Monoclonal Antibody (clone LT78A) (Kingfisher, CAT#WS0823L-100) |
| Llama CD2 or CD6 predicted Monoclonal Antibody (clone LH43A) (Kingfisher, CAT#WS0815L-100) |
| Llama CD2 or CD6 Predicted Monoclonal Antibody (clone LT10A) (Kingfisher, CAT#WS0819L-100) |
| Llama CD44 Monoclonal Antibody (clone LT36A) (Kingfisher, CAT#WS0821L-100) |
| Llama CD45 Predicted Monoclonal Antibody (clone LT12A) (Kingfisher, CAT#WS0820L-100) |
| Llama CD5 Predicted Monoclonal Antibody (clone LT3A) (Kingfisher, CAT#WS0817L-100) |
| Llama CD8 Monoclonal Antibody (clone LT5A) (Kingfisher, CAT#WS0818L-100) |
| Llama MHC II Monoclonal Antibody (clone LT1A) (Kingfisher, CAT#WS0816L-100) |
| Llama Pan B cell Monoclonal Antibody (clone LH41A) (Kingfisher, CAT#WS0814L-100) |
| Llama Pan T cell Monoclonal Antibody (clone LT97A) (Kingfisher, CAT#WS0824L-100) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1031Y-100) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1031Y-025) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1031Y-005) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1031Y-500) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1321Y-100) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1321Y-025) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1321Y-005) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1321Y-500) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey IL-8 (CXCL8) Polyclonal Antibody (Kingfisher, CAT#KP1669Y-100) |
| Cynomolgus Monkey IL-8 (CXCL8) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1670Y-050) |
| Cynomolgus Monkey IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1671Y-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1672H-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1010D-100) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1010D-025) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1010D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1010D-500) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 100 microgrrams (Kingfisher, CAT#RP1322D-100) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 25 microgrrams (Kingfisher, CAT#RP1322D-025) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1322D-005) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP1322D-500) |
| Canine BAFF (TNFSF13B) Polyclonal Antibody (Kingfisher, CAT#KP1694D-100) |
| Canine BAFF (TNFSF13B) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1695D-050) |
| Canine BAFF (TNFSF13B) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1696D-003) |
| Canine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0891D-003) |
| Canine Fas Ligand (FasL) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1288D-003) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1647CT-100) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1647CT-025) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1647CT-005) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1647CT-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0002B-100) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0002B-025) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP0002B-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP0002B-500) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0665B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-15 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0672B-003) |
| Bovine IL-17A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0673B-003) |
| Bovine IL-2 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1100B-003) |
| Bovine TNF alpha (TNFSF2) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0675B-003) |
| Bovine VEGF-A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0676B-003) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| Bovine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1319B-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL2 (MCP-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0659B-003) |
| Bovine CCL3 (MIP-1 alpha) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1143B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Bovine CD40 Ligand Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1211B-003) |
| Bovine CXCL10 (IP-10) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0662B-003) |
| Bovine CXCL9 (MIG) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0661B-003) |
| Bovine Erythropoietin (EPO) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1585B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-15 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0672B-003) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0003E-100) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0003E-025) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0003E-005) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0003E-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Zebra Finch SCF (Stem Cell Factor) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1579ZN-005) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0013B-100) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0013B-025) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0013B-005) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0013B-500) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0002B-100) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0002B-025) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP0002B-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP0002B-500) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0311B-100) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0311B-025) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0311B-005) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0311B-500) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine/Caprine/Ovine IL-5 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0139B-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

LC Laboratories(LC Labs)公司成立于1980年,一直专注于信号转导,肿瘤以及其他临床前试剂的研究和生产,主要提供抗癌物质、酶抑制剂、激活剂和离子通道试剂。LC Labs公司不但拥有大规模的制备液相色谱纯化能力,也开发和优化了大量的具有自主知识产权的低成本高纯度生成方法,其生产的小分子试剂纯度高、价格低和销量大。
1980年,LC Labs是PMA(佛波醇12-豆蔻酸 13醋酸;TPA)的全球主要生产商,36年来的销售量超过150,000瓶;1989年为研究试剂市场提供第一个纯度高价格低的毒萝卜素;1990年提供第一个纯度高价格低的冈田酸;1991年提供第一个纯度高价格低的花萼海绵诱癌素A,并且持续是这种广泛使用的磷酸酶抑制剂的全球主要生产商;1995年提供第一个异构体级别纯度的低价格Gö 6976;1996年提供第一个纯度高价格低的罗霉素A1;2002年提供第一个纯度高价格低的雷帕霉素(抗真菌抗生素);同年,提供第一个纯度高、价格低的FK-506;2003年提供第一个纯度高价格低的来普霉素B;2004年提供第一个纯度高价格低的星孢菌素;同年,提供第一个纯度高价格低的环巴胺;2007年,LC Labs公司为临床前肿瘤相关研究引入第一组纯度高价格低的常用蛋白激酶抑制剂。
热销产品:
Bortezomib硼替佐米(99%,97%)
Cyclosporine-A环胞霉素A
Cyclopamine环巴胺
17-DMAG,Hydrochloride SaltHSP90抑制剂
Everolimus依维莫司
FK-506他克莫司
Forskolin腺苷酸环化酶激活剂
Gefitinib吉非替尼
Leptomycin B细霉素B 出核转运抑制剂
LY 294002PI3-K抑制剂
PD98059MEK抑制剂
RoscovitineCDK抑制剂
Rapamycin雷帕霉素
SB 202190MAPK抑制剂
SB203580P38MAPK抑制剂
SP600125JNK抑制剂
Staurosporine星孢菌素
UO126MAPK抑制剂
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://atlas.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="LC Laboratories"> LC Laboratories
艾美捷科技特约代理Arbor Assays的全系列产品。
Arbor Assays公司成立于2007年,位于密歇根州的安娜堡,公司的三位主创始人均为有多年科研经验的生命和临床科学家。其宗旨是为临床使用的重要生物分子建立高质量的检测和免疫测试产品。在生物领域建立健全的免疫检测和酶活性试剂盒以定量生物分子。
Arbor Assays公司的主要产品包括:
DetectX® Kits
Inhibitors & Activators
AbX® Antibodies & Affinity Resins
Detection Systems
Components & Ancillary Reagents
" data-original="http://atlas.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Arbor Assays"> Arbor Assays
Swant专注于钙结合蛋白相关产品的研发和销售,产品包括:钙结合蛋白抗体、纯化的重组蛋白、钙离子通道和钙泵抗体以及其他抗体和ELISA。
Antibodies to Calbindin D-28k, Calretinin, Parvalbumin, Calmodulin and to Na2+-Ca2+-exchangers, Ca2+ pumps, neurotransmitters, as well as their respective antigens. Superb staining of subpopulation of neurons or glial cells in various species, including humans. Selective staining of various types of cancers. Our mono- and polyclonal antibodies are of high titer and of high specificity. They can be used in immunohistochemistry and immunoblots at dilution of more than 1:5'000 (Avidin-Biotin-Method). The recombinant antigens have been purified by HPLC and FPLC. The products are supplied in lyophilized form and are accompanied by detailed product description as well as by a method sheet.
Swant 的主要产品包括:
(1)Antibodies against Ca2+ - binding proteins
Calbindin
Calretinin
Parvalbumin
Others
(2)Purified and recombinant proteins
Calbindin
Calretinin
Parvalbumin
Others
(3)Antibodies against Ca2+ exchangers and Ca2+ pumps
Ca2+ - exchangers
Ca2+ - pumps
(4)Various
Antibodies against insulin-like growth factors
Antibodies against neurotransmitters
Antibodies against components of the renin-angiotensin system
Miscellaneous antibodies
(5)ELISA KITS
Sandwich-ELISA
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
< " data-original="http://atlas.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Swant"> Swant
E&K Scientific公司成立于1975年,是生物技术和制药研究实验室提供实验试剂和仪器设备的主要供应商,有着超过40年的经验。
At E&K Scientific our mission is to excel in the distribution of life science research supplies by offering an unparalleled customer experience centered on technical expertise, innovation, and personalized service.
E&K offers almost 50 years of experience as a premier provider of laboratory supplies and instrumentation to the Academic, Biotech, and Pharmaceutical Research Laboratories. The company was founded in 1975 by Egon and Kay Ruf and their son, Brian Ruf, took over as President and CEO in 2000.
E&K Scientific公司的主要产品包括:
Biological Buffers
Blotting & Electrophoresis
Cell Culture
Chromatography Supplies
DNA/RNA Purification
Equipment & Instruments
Filtration & Separation
Gloves & Apparel
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://atlas.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="E&K Scientific"> E&K Scientific
Rockland公司为生命科学领域提供丰富的、高质量的抗体,包括载脂蛋白、细胞周期/凋亡、细胞因子、细胞信号蛋白、酶类、细胞外基质、转录因子(NFkB)和泛素(Ubiquitin)等识别抗体,应用范围包括Western blot、免疫组化、免疫荧光和ELISA等。另外,Rockland也生产特别齐全的二抗,包括纯化、生物素、HRP/ALP、荧光标记二抗,应用十分广泛。
Established in 1962, Rockland Immunochemicals, Inc. (Rockland) is a global biotechnology company manufacturing leading edge research tools for basic, applied, and clinical research in functional genomics, gene therapy, and drug discovery markets. Rockland is a privately held company, which operates a manufacturing facility with antibody and protein production capabilities located near Philadelphia, Pennsylvania, USA. Global markets are supported through a highly specialized network of key distributors. Our laboratories consist of over 60,000 square feet, producing antibodies and antibody-based tools that are used to help define mechanisms underlying cell function and disease.
Rockland公司产品主要包括:
Primary Antibodies
Secondary Antibodies
Blocking Buffers
Blood Products
Collagen Products
Epi-Plus®
GFP Antibodies
Phospho-specific
Proteins & Peptides
Signaling Antibodies
TrueBlot®
Melanoma Cell Lines
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://atlas.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Rockland"> RocklandNanostructured & Amorphous Materials, Inc.致力于纳米材料科技的应用。主要的业务包括:生产、研发、加工纳米级和非结晶材料。
Nanostructured & Amorphous Materials Inc. (NanoAmor) was founded in Los Alamos, New Mexico, USA, in September 2001. We are a leading nanomaterials company involved in all aspects of the business: manufacturing, research and development, processing, supplying and marketing of nanostructured materials and their dispersions.
Nanostructured & Amorphous Materials的主要产品包括:
Application-Oriented Carbon-Nanotubes Products
Carbon Nanotubes & Nanofibers
Carbon Nanotube Dispersions
Elements, Oxides, Carbides & Nitrides Nanoparticles
Fullerene
Graphenes, Graphene Oxides & Graphene Nanoplatelets
Graphene Film
Nanopowder Dispersions
Nanowires & Nanorods
Amorphous Ribbons
Nanocrystalline Ribbons
Amorphous & Nanocrystalline Cores
Amorphous and Nanocrystalline Magnetic Bars
Amorphous & Nanocrystalline Powders
Amorphous Brazing Foils
Superhard Materials
Surface-Modified Oxide Nanoparticles
| 品名 | 货号 | 规格 |
| CNTs Additives for Lithium-ion Battery | 1376YJ | 1kg; |
| Carbon Nanotubes Fibers | 1356YJ | meter; |
| Carbon Nanotubes Papers | 1348YJ | piece; |
| Carbon Nanotubes Films | 1350YJ | piece; |
| Carbon Nanotubes Films | 1351YJ | 咨询 |
| Water-based carbon nanotubes coatings | 1332YJ | kg; |
| Water-based carbon nanotubes coatings | 1333YJ | kg; |
| Antistatic carbon-nanotubes coatings | 1331YJA | kg; |
| Antistatic carbon-nanotubes coatings | 1331YJB | kg; |
| Conductive/heating carbon-nanotubes coatings | 1378YJA | kg; |
| 20wt% CNTs/80wt% ABS Masterbatch | 1335YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% HDPE Masterbatch | 1337YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% HIPS Masterbatch | 1338YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% LLDPE Masterbatch | 1339YJ | 1kg; 5kg; 10kg; |
| 20wt% CNTs/80wt% PA6 Masterbatch | 1340YJ | 1kg; 5kg; 10kg; |
| 20wt% CNTs/80wt% PP Masterbatch | 1341YJ | 1kg; 5kg; 10kg; |
| 0.2 wt% SWCNTs (> 95%, D < 2 nm)/Water Dispersion | 8040YJ | 500g; |
| 0.2 wt% SWCNTs-COOH (> 95%, OD 1-2 nm)/Water Dispersion | 8042YJ | 500g; |
| 2 wt% MWCNTs (> 98%, D 5-15 nm)/Water Dispersion | 8028YJ | 500ml; |
| 2 wt% MWCNTs-COOH (> 98%, D 5-15 nm)/Water Dispersion | 8027YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/Water Dispersion | 8030YJ | 500 ml; |
| 10 wt% MWCNTs-COOH (>98%, D 30-80 nm)/Water Dispersion | 8029YJ | 500 ml; |
| 0.2 wt% SWCNTs (> 95%, D < 2 nm)/Water Paste | 8038YJ | kg; |
| 0.2 wt% SWCNTs-COOH (> 95%, OD 1-2 nm)/Water Paste | 8039YJ | 500g; kg; |
| 2 wt% MWCNTs (> 95%, D 5-15 nm)/Water Paste | 8032YJ | kg; |
| 2 wt% MWCNTs-COOH (> 95%, D 5-15 nm)/Water Paste | 8033YJ | kg; |
| 10 wt% MWCNTs (> 95%, D 30-80 nm)/Water Slurry | 8034YJ | kg; |
| 10 wt% MWCNTs-COOH (> 95%, D 30-80 nm)/Water Paste | 8035YJ | kg; |
| 12-14 wt% MWCNTs (> 95%, D 30-80 nm)/Water Paste | 8036YJ | kg; |
| 12-14 wt% MWCNTs-COOH (>95%, D 30-80 nm)/Water Paste | 8037YJ | kg; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/BA Dispersion | 8116YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/DMAC Dispersion | 8118YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/DMF Dispersion | 8115YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/IPA Dispersion | 8117YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/NMP Dispersion | 8114YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/BA Dispersion | 8124YJ | 500 ml; |
| 8-10 wt% MWCNTs (> 98%, D 30-80 nm)/BA Dispersion | 8123YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/DMAC Dispersion | 8126YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/DMAC Dispersion | 8125YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/DMF Dispersion | 8122YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/DMF Dispersion | 8121YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/IPA Dispersion | 8130YJ | 500 ml; |
| 8-10 wt% MWCNTs (> 98%, D 30-80 nm)/IPA Dispersion | 8129YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/NMP Dispersion | 8120YJ | 500 ml; |
| 5 wt% MWCNTs (> 98%, D 30-80 nm)/NMP Dispersion | 8119YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/PMA Dispersion | 8128YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/PMA Dispersion | 8127YJ | 500 ml; |
| Fullerence powder (C60, 95+%) | 8072YJ | 1g; 5g; |
| Fullerence powder (C60, 98+%) | 8073YJ | 1g; 5g; |
| Fullerence powder (C60, 99+%) | 8074YJ | 1g; 5g; |
| Fullerene powder (C60, 99.5+%) | 8075YJ | 1g; 5g; |
| Fullerene powder (C60, 99.9+%) | 8076YJ | 1g; 5g; |
| Fullerence powder (C70, 95+%) | 8077YJ | 1g; 5g; |
| Fullerence powder (C70, 98+%) | 8078YJ | 1g; 5g; |
| Fullerence powder (C70, 99+%) | 8079YJ | 1g; 5g; |
| Fullerenol Powder (hydroxylated fullerence C60) | 8080YJ | 1g; 10g; |
| Three-Dimensional Graphene (> 60 wt%, D 6-8 um, 3-4 layers) | 8109YJ | 1g; 5g; |
| 1.0-1.5 wt% Graphenes (> 98 wt%, Dia. 4-6 um, < 10 layers)/NMP paste | 8064YJ | 1g (graphene); 5g (graphene); |
| Highly Elastic Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8095YJ | 1 cylinder; 5 cylinders; |
| Ultra-light Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8093YJ | 1 cylinder; 5 cylinders; |
| Carbon Nanotubes (10 wt%) Doped Graphene Aerogel (Dia. 1.2 cm, Height 1.2 cm) | 8090YJ | 1 cylinder; 5 cylinders; |
| Carbon Nanotubes (10 wt%) Doped Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8091YJ | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (47 wt% Fe3O4, Dia. 1 cm, Height 1 cm) | 8096YJA | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (47 wt% Fe3O4, Dia. 2 cm, Height 2 cm) | 8096YJB | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (63 wt% Fe3O4, Dia. 1 cm, Height 1 cm) | 8097YJA | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (63 wt% Fe3O4, Dia. 2 cm, Height 2 cm) | 8097YJB | 1 cylinder; 5 cylinders; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam (nickel foam etched, thickness 1-1.2 mm) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| 1-3 wt% Graphene Oxide (> 98 wt%, D 1-5 um, 1-2 layers)/Water Gel, pH = 3-4 | 8047YJB34 | 1g (graphene oxide); 5g (graphene oxide); |
| Graphene Oxide Paper (Dia. 9 cm, thickness 10 um) | 8089YJ | 1 piece; 5 pieces; |
| Industrial-Grade Graphene Nanoplatelets (> 90 wt%, D 2-13 um, < 30 layers) | 8055YJ2 | 50g; 250g; 1kg; |
| 5 wt% Graphene Nanoplatelets (> 90 wt%, D 2-16 um, < 30 layers)/NMP Paste | 8059YJ | kg (paste); |
| Industrial-Grade Graphene-Nanoplatelets/Carbon-Nanotubes Composites (> 90 wt%) | 8071YJ | 50g; 100g; |
| 5 wt% (Graphene Nanoplatelets & Carbon Nanotubes)/Water Paste | 8060YJ | kg (paste); |
| 5 wt% (Graphene Nanoplatelets & Carbon Nanotubes)/NMP Paste | 8061YJ | kg (paste); |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Silver Nanopowder (Ag, 99.9+%, 20 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7031HW | 500ml; 1L; |
| Silver Nanopowder (Ag, 99.9+%, 50 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7033HW | 500ml; |
| Silver Nanopowder (Ag, 99.9+%, 100 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7035HW | 500ml; |
| Silver Nanopowder (Ag, 99.9+%, 200 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7038HW | 500ml; |
| Gold Nanopowder (Au, 99.99%, 20 nm) 0.1 - 1 wt% Dispersion in Water | 7041HW | 500ml; |
| Platinum Nanopowder (Pt, 99.9+%, 20-30nm) 0.1wt% Dispersion in Water | 0488HW | 500ml; |
| Palladium Nanopowder (Pd, 99.99%, 20 nm) 0.1 - 1 wt% Dispersion in Water | 7051HW | 500ml; |
| Palladium Nanopowder (Pd, 99.9+%, 10 nm) 0.1wt% Dispersion in Water | 0466HW | kg; |
| Germanium Nanopowder (Ge, 99.9+%, 400 nm) Dispersed in 850ml of Ethanol | 0388HW | 咨询 |
| Aluminum Oxide (alpha, 20 wt%, 30-60nm) in Water | 7017WJWA | 1kg; |
| Aluminum Oxide (gamma, 20 wt%, 30 nm) in Water | 7017WJWG | 1kg; |
| Aluminum Oxide (gamma, 20 wt%, 10 nm) in water | 7016WJWG | 1kg; |
| CuO, 1 wt%, in water, APS 30 nm | 9019WJ | kg; |
| Silicon Oxide (15 wt%, 30 nm) in water | 7019WJ | 30kg; |
| Silicon Oxide (25 wt%, 30 nm) in water | 7015WJ | 1kg; |
| Silicon Oxide (25 wt%, 30 nm) in water | 7016WJ | 1kg; 10kg; |
| Titanium Oxide (Rutile, 40 wt%, 30-50 nm) in water | 7013WJWR | 1kg; |
| Titanium oxide TiO2 (40wt%, Rutile, 30-50 nm ) in Isopropanol | 5006WJ | kg; |
| Titanium Oxide (TiO2, Rutile, >99.5%, 5-30 nm,15 wt%) in water | 7012WJWR | 1kg; |
| Titanium Oxide (Anatase, 20 wt%, 5-30 nm) in IPA | 7014WJWA | 1kg; |
| Titanium Oxide (Anatase, ATO doped, 20 wt%, 15-25 nm) Slurry | 7030WJ | 5kg; |
| Titanium Oxide (Anatase, 20 wt%, 5-30 nm) in water | 7012WJWA | 1kg; |
| Titanium Oxide (Anatase, 15 wt%, 5-30 nm) in water | 7011WJWA | 1kg; |
| Titanium Oxide (TiO2, Anatase, >99.5%, 15 nm, 15 wt%) in water, negatively charged | 7011WJWANC | 咨询 |
| Titanium Oxide Nanopowder (anatase, 5 wt%, 10-20 nm) in ethanol | 7019HT | 1L; 5L; |
| Zinc Oxide (20 wt%, 40 nm) in water | 7006WJ | 1L |
| Indium Tin Oxide (ITO, 30 wt%, 20-30 nm) in Water | 7026HZW | 100g; |
| Silver nanowires (Dia. 70 - 80 nm, Length > 10 um) | 0475HW6 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver nanowires (Dia. 30 - 50 nm, Length > 10 um) | 0475HW5 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver Nanowires (Dia. 20 - 30 nm, Length > 10 um) | 0475HW4 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW2E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW2I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in water) | 0475NW2W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW3E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW3I | 1 g (Ag nanowires); 2 g (Ag nanowires); 3 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in water) | 0475NW3W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW5E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW5I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in water) | 0475NW5W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW6E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW6I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in water) | 0475NW6W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Single-walled Carbon nanotubes - 60%SWNTs (90%CNTs) | 1283YJ | 1g; 5g; |
| SWNT-OH (90% CNTs, 60% SWNTs) | 1285YJF | 1g; 5g; |
| SWNT-COOH (90% CNTs, 60% SWNTs) | 1287YJF | 1g; 5g; |
| Short SWNTs (90% CNTs, 60% SWNTs) | 1281YJS | 1g; 5g; |
| SWNT-OH (> 60%, OD 1-2 nm, Length 1-3 um) | 1285YJFS | 1g; |
| SWNT-COOH (> 60%, OD 1-2 nm, Length 1-3 um) | 1287YJFS | 1g; |
| High-Purity SWNTs (> 95%, OD < 2 nm, Length 5-30 um) | 1288YJ | g; |
| Single-walled carbon nanotubes - 90%SWNTs (95%CNTs) | 1284YJ | g; 5g; |
| SWNT-OH (95% CNTs, 90% SWNTs) | 1286YJF | 1g; |
| SWNT-COOH (95% CNTs, 90% SWNTs) | 1288YJF | 1g; |
| SWCNTs (> 90%, OD 1-2 nm, Length 1-3 um) | 1246YJS | 1g; 5g; |
| Single-Walled Carbon Nanotubes (90+%), -OH Functionalized | 1586YJF | 1g; |
| Single-Walled Carbon Nanotubes (90+%), -COOH Functionalized | 1588YJF | 1g; |
| High-Purity SWNTs (> 95%, OD < 2 nm, Length 5-30 um) | 1288YJ | 1g; |
| High-Purity SWNTs, -OH functionalized (> 95%, OD 1-2 nm, Length 5-30 um) | 1368YJF | 1g; |
| High-Purity SWNTs, -COOH functionalized (> 95%, OD 1-2 nm, Length 5-30 um) | 1369YJF | 1g; |
| High-Purity Short SWNTs (> 95%, OD 1-2 nm, Length 1-3 um) | 1372YJ | 1g; |
| High-Purity Short SWNTs, -OH Functionalized (> 95%, OD 1-2 nm, Length 1-3 um) | 1373YJF | 1g; |
| High-Purity Short SWNTs, -COOH Functionalized (> 95%, OD 1-2 nm, Length 1-3 um) | 1374YJF | 1g; |
| High-Purity SWNTs (> 95%), -NH2 functionalized | 1370YJF | 1g; 5g; |
| High-Purity Short SWNTs (> 95%), -NH2 functionalized | 1371YJFS | 1g; 5g; |
| High-Purity SWNTs (> 95 %, surface area > 1,075 m2/g) | 1300YJ | 1g; |
| DWNTs (> 60%, OD 2-4 nm, Length ~50 um) | 1280YJD | 1g; 5g; 25g; |
| DWNTs-COOH (> 60%, OD 2-4 nm, Length ~50 um) | 1281YJD | g; |
| Multi-Walled Carbon Nanotube -MWNT (98%, OD 4-6 nm) | 1389YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (98%, OD 5-15 nm) | 1203YJ | 10g; 25g; |
| Multi-walled carbon nanotube -MWNT (99%, OD 5-15 nm) | 8101YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (95+%, OD 8-15 nm) | 1204YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 10-20 nm) | 1205YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 20-30 nm) | 1229YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (98+%, OD 30-50 nm) | 1231YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 30-80 nm) | 1233YJ | 10g; 25g; |
| Short MWNT (98+%, OD 4-6 nm, Length 0.5-2 um) | 1392YJS | 5g; |
| Short MWNT (98+%, OD 5-15 nm, Length 0.5-2 um) | 1225YJS | 5g; |
| Short MWNT (99+%, OD 5-15 nm, Length 0.5-2 um) | 8104YJS | 5g; |
| Short MWNT (95+%, OD 8-15 nm, Length 0.5-2 um) | 1235YJS | 5g; |
| Short MWNT (>98%, OD 10-20 nm, Length 0.5-2 um) | 1236YJS | 10g; |
| Short MWNT (98+%, OD 20-30 nm, Length 0.5-2 um) | 1237YJS | 5g; |
| Short MWNT (98+%, OD 30-50 nm, Length 0.5-2 um) | 1238YJS | 5g; |
| Short MWNT (98+%, OD 30-80 nm, Length 0.5-2 um) | 1227YJS | 5g; |
| Graphitized MWNT (99.9%, OD 8-15 nm) | 1219YJ | 10g; 25g; |
| Graphitized MWNT (99.9%, OD 10-20 nm) | 1220YJ | 10g; |
| Graphitized MWNT (99.9%, OD 20-30 nm) | 1221YJ | 5g; |
| Graphitized MWNT (99.9%, OD 30-50 nm) | 1222YJ | 5g; |
| Graphitized MWNT (99.9%, OD 30-80 nm) | 1223YJ | 5g; |
| Industrial-grade MWNT (95+%, OD 4-6 nm) | 1395YJ | 1kg; |
| Industrial-Grade MWNT (95+%, OD 5-15 nm) | 1201YJG | 1kg; |
| Industrial-grade MWNT (95%, OD 8-15 nm) | 1201YJA | 1kg; |
| Industrial-grade MWNT (95+%, OD 10-20 nm) | 1201YJB | 1kg; |
| Industrial-grade MWNT (95+%, OD 10-30 nm) | 1201YJC | 1kg; |
| Industrial-grade MWNT (95+%, OD 20-40 nm) | 1201YJD | 1kg; |
| Industrial-Grade MWNT (95+%, OD 30-80 nm) | 1201YJE | 1kg; |
| MWNT-OH (98+%, OD 4-6 nm) | 1390YJF | 10g; |
| MWNT-OH (98+%, OD 5-15 nm) | 1261YJF | 5g; |
| MWNT-OH (99+%, OD 5-15 nm) | 8103YJF | 5g; |
| MWNT-OH (95+%, OD 8-15 nm) | 1262YJF | 5g; |
| MWNT-OH (98+%, OD 10-20 nm) | 1263YJF | 5g; |
| MWNT-OH (98+%, OD 20-30 nm) | 1264YJF | 5g; 25g; 100g; |
| MWNT-OH (98+%, OD 30-50 nm) | 1265YJF | 5g; |
| MWNT-OH (98+%, OD 30-80 nm) | 1266YJF | 5g; |
| Short MWNT-OH (98+%, OD 4-6 nm, Length 0.5-2 um) | 1393YJF | 5 g; 100 g; |
| Short MWNT-OH (98+%, OD 5-15 nm, Length 0.5-2 um) | 1247YJF | 5g; |
| Short MWNT-OH (99+%, OD 5-15 nm, Length 0.5-2 um) | 8106YJF | 5g; |
| Short MWNT-OH (95+%, OD 8-15 nm, Length 0.5-2 um) | 1248YJF | 5g; |
| Short MWNT-OH (98+%, OD 10-20 nm, Length 0.5-2 um) | 1249YJF | 5g; |
| Short MWNT-OH (98+%, OD 20-30 nm, Length 0.5-2 um) | 1251YJF | 5g; |
| Short MWNT-OH (98+%, OD 30-50 nm, Length 0.5-2 um) | 1252YJF | 5g; |
| Short MWNT-OH (98+%, OD 30-80 nm, Length 0.5-2 um) | 1253YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 8-15 nm) | 1224YJF | 1g; |
| Graphitized MWNT-OH (99.9%, OD 10-20 nm) | 1228YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 20-30 nm) | 1235YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 30-50 nm) | 1239YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 30-80 nm) | 1240YJF | 1g; 5g; |
| Industrial-grade MWNT-OH (95+%, OD 5-15 nm) | 1201YJI | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 8-15 nm) | 1201YJL | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 10-30 nm) | 1207YJF | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 20-40 nm) | 1208YJF | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 30-80 nm) | 1209YJF | 1kg; |
| MWNT-COOH (98+%, OD 4-6 nm) | 1391YJF | 10g; |
| MWNT-COOH (98+%, OD 5-15 nm) | 1267YJF | 5g; |
| MWNT-COOH (99+%, OD 5-15 nm) | 8102YJF | 10g; |
| MWNT-COOH (95+%, OD 8-15 nm) | 1268YJF | 5g; |
| MWNT-COOH (98+%, OD 10-20 nm) | 1269YJF | 5g; |
| MWNT-COOH (98+%, OD 20-30 nm) | 1270YJF | 5g; |
| MWNT-COOH (98+%, OD 30-50 nm) | 1271YJF | 5g; |
| MWNT-COOH (98+%, OD 30-80 nm) | 1272YJF | 5g; |
| Short MWNT-COOH (98+%, OD 4-6 nm, Length 0.5-2 um) | 1394YJF | 5g; |
| Short MWNT-COOH (98+%, OD 5-15 nm, Length 0.5-2 um) | 1254YJF | 5g; |
| Short MWNT-COOH (99+%, OD 5-15 nm, Length 0.5-2 um) | 8105YJF | 5g; |
| Short MWNT-COOH (95+%, OD 8-15 nm, Length 0.5-2 um) | 1255YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 10-20 nm, Length 0.5-2 um) | 1256YJF | 5g; |
| Short MWNT-COOH (98+%, OD 20-30 nm, Length 0.5-2 um) | 1257YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 30-50 nm, Length 0.5-2 um) | 1259YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 30-80 nm, Length 0.5-2 um) | 1273YJF | 1g; 5g; |
| Graphitized MWNT-COOH (99.9%, OD 8-15 nm) | 1241YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 10-20 nm) | 1242YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 20-30 nm) | 1243YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 30-50 nm) | 1244YJF | 1g; 5g; |
| Graphitized MWNT-COOH (99.9%, OD 30-80 nm) | 1245YJF | 1g; 5g; |
| Industrial-grade MWNT-COOH (95+%, OD 5-15 nm) | 1201YJH | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 8-15 nm) | 1201YJK | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 10-30 nm) | 1210YJF | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 20-40 nm) | 1216YJF | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 30-80 nm) | 1218YJF | 1kg; |
| Aligned MWNT (98+%, OD 8-15 nm, Length: 30-50 um) | 1215YJA | 25g; |
| Carbon nanofibers (70+%, D = 200-600 nm, L = 5-50 um) | 1177YJ | 10g; |
| Carbon Nanofibers (95+%, D = 50-200 nm, L = 1-15 um) | 8107YJ | 10g; |
| Graphitized carbon nanofibers (95+%, OD = 50-200 nm, L = 1-15 um) | 1178YJ | 10g; |
| Graphene (> 98 wt%, D > 50 um, < 3 layers) | 2191YJ | 1g; 5g; |
| Graphene Oxide (> 99 wt%, D 0.5-3 um, < 3 Layers) | 2192YJ | 1g; 5g; |
| Graphene Nanoplatelets (> 99.5 wt%, D 5-10 um, < 20 layers) | 8056YJ | 1g; 5g; 25g; |
| Industrial-Grade Graphene Nanoplatelets (> 90 wt%, D 2-16 um, < 30 layers) | 8055YJ | 50g; 250g; 1kg; |
| *60% Ni/38% MWNT (95+%, OD 8-15 nm) | 1293YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 10-20 nm) | 1294YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 20-30 nm) | 1295YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 30-50 nm) | 1296YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 30-80 nm) | 1297YJ | 10g; |
| MWNT-NH2 (95+%, OD 8-15 nm, 0.45 wt% amino) | 1562YJF | 5g; |
| Nitrogen-doped MWNTs (98%, OD 30-80 nm) | 8054YJ | 5g; |
| Large inner diameter thin-walled multi-walled carbon nanotubes | 1563YJF | 5g; |
| Coiled CNTs (60+%, OD 100-200 nm, Length 1-10 um) | 1298YJ | 5g; |
| Silver Nanopowder (Ag, 99.99%, 400 nm ) | 0487HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 200 nm ) | 0479HW | 咨询 |
| Silver Nanopowder (Ag, 99.99%, 100 nm ) | 0489HW | 咨询 |
| Silver Nanopowder (Ag, 99%, 90-210 nm) | 0471CD | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 80 nm ) | 0475HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 80 nm, w/~0.3% PVP ) | 0476HW | 咨询 |
| Silver Nanopowder (Ag, 99.9% , 40 nm ) | 0473HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 40 nm, w/~0.3% PVP ) | 0474HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 30-50 nm, w/0.2 wt% PVP) | 0477YD | 咨询 |
| Silver Nanopowder (Ag, 35 nm, 99.5%, metal basis) | 0476JY | 咨询 |
| Silver Nanopowder (Ag, 99.9% , 20 nm ) | 0477HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 20 nm, w/~0.3% PVP ) | 0478HW | 咨询 |
| Aluminum Powder (99.9%, 500 um) | 0156HW | 咨询 |
| Aluminum Powder (99.9%, 50 um) | 0154HW | 咨询 |
| Aluminum Powder (99.9%, 5 um) | 0152HW | 咨询 |
| Aluminum Nanoparticles (99.9%, 500 nm) | 0150HW | 咨询 |
| Aluminum Nanopowder (Al, 99.9+%, 70-80 nm) | 0137HW | 咨询 |
| Aluminum Nanopowder (99.9+%, 70-80 nm, w/PVP) | 0140HW | 咨询 |
| Aluminum Nanopowder (Al, 99.9+%, 40-50 nm) | 0138HW | 咨询 |
| Aluminum Nanopowder (99.9+%, 40-50 nm, w/PVP) | 0139HW | 咨询 |
| Aluminum Nanopowder (Al, 99+%, metal basis, 18 nm) | 0136JY | 咨询 |
| Gold (Au) Nanopowder (99.9%, 50-100 nm) | 0795CD | 咨询 |
| Gold (Au) Nanopowder (25nm, 99.9%) | 8801HW | 咨询 |
| Gold (Au) Nanopowder (10-20 nm, 99.95%) | 8796HW | 咨询 |
| Gold (Au) Nanopowder (10nm, 99.9%) | 8799HW | 咨询 |
| Bismuth Nanopowder (Bi, 99.9%, 80-100 nm) | 0832HW | 咨询 |
| Bismuth Nanopowder (Bi, 99.5%, 40-60 nm) | 0831HW | 咨询 |
| Nano Activated Carbon (C, 88+%, 100 nm) | 1211NH | 咨询 |
| Diamond Nanopowder (synthesized, 55-70%, 4-15nm) | 1311JGY | 咨询 |
| Diamond Nanopowder (synthesized, 98+%, 3-10 nm) | 1321JGY | 咨询 |
| Diamond Nanopowder (synthesized, 97%, 3-6 nm) | 1350SL | 咨询 |
| Graphite Nanopowder (400 nm, 99.9%) | 1250HT | 咨询 |
| *Cobalt Nanopowder, Carbon Coated (Co, 99%, 40 nm) | 0286HW | 咨询 |
| *Cobalt Nanopowder (Passivated, 99.8%, 28 nm) | 0276JY | 咨询 |
| *Chromium Nanopowder (Cr, 99.5%, 50 nm) | 0240XX | 咨询 |
| *Copper Nanopowder (Cu, 99%, 500 nm) | 0293HW | 100g; |
| *Copper Nanopowder (Cu, 99.9%, 200 nm) | 0290HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 100 nm) | 0298HW | 25g; |
| *Copper Nanopowder (Partially Passivated, 99+%, 80 nm) | 0294HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 70 nm) | 0291HW | 25g; |
| *Copper Nanopowder (Cu, 99.5%, 50-80 nm) | 0292HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 40 nm) | 0295HW | 25g; |
| *Copper Nanopowder (Cu, carbon coated, 99.8%, 25 nm) | 0297JY | 5g; |
| *Iron Nanopowder (Fe, 99.9%, 500nm) | 0272YM | 100g; 1kg; |
| *Iron Nanopowder (Fe, 99.9%, 100 nm) | 0264HW | 25g; |
| *Iron Nanopowder (Fe, 99.9%, 70 nm) | 0263HW | 25g; 100g; |
| *Iron Nanopowder (Fe, 99.9%, 40 nm) | 0262HW | 25g; 100g; |
| *Iron nanopowder, carbon coated (Fe/C, 99.6%, 25 nm) | 0267JY | 25g; |
| Germanium Nanopowder (Ge, 99.9+%, 600 nm) | 0327HW | 25g; |
| Germanium Nanopowder (Ge, 99.9%, 500 nm) | 0331HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 400 nm) | 0326HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 300 nm) | 0325HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 200 nm) | 0323HW | 100g; kg; |
| Germanium Nanopowder (Ge, 99.9+%, 150 nm) | 0322HW | 咨询 |
| Germanium Nanopowder (Ge, 99.9+%, < 100 nm) | 0322HH | 咨询 |
| Germanium Nanopowder (Ge, 99.9+%, 20-50 nm) | 0321HW | 5g; |
| Iridium Nanopowder (Ir, 99.95%, 20-30 nm), wet powder in Deionized Water | 0771HW | 咨询 |
| *Molybdenum Nanopowder (Mo, 99.5%, 70 nm) | 0423HW | 咨询 |
| Niobium Nanopowder (Nb, 99.9%, 40-60 nm) | 0411HW | 咨询 |
| *Nickel Nanopowder (Ni, 99%, 800 nm) | 0302HW | 咨询 |
| *Nickel Nanopowder (Ni, 99%, 400 nm) | 0301HW | 100g; 1kg; |
| *Nickel Nanopowder (Ni, 99+%, 300 nm) | 0289HW | 1kg; |
| *Nickel Nanopowder (Ni, 99.5%, 100 nm) | 0285HW | 25g; |
| *Nickel Nanopowder (Ni, 99.9%, 80 nm) | 0284HW | 300g; |
| *Nickel Nanopowder (Ni, 99.5%, 70 nm) | 0288HW | 25g; |
| *Nickel Nanopowder (Ni, 99.5%, 40 nm) | 0283HW | 25g; |
| *Nickel Nanopowder, carbon coated (Ni/C, 99.9%, 20 nm) | 0287JY | 5g; |
| Palladium Nanopowder (Pd, 99.95%, 20-30 nm) | 0462HW | 咨询 |
| Platinum Nanopowder (Pt, 99.95%, 20-30 nm) | 0782HW | 咨询 |
| Platinum Nanopowder, PVP coated (Pt, 99.95%, 20-30 nm) | 0787HW | 1g; |
| Platinum Nanopowder (Pt, 99.9%, 20-30 nm) | 0786HW | 1g; 5g; |
| Rhodium Nanopowder (Rh, 99.95%, 20-30 nm) | 0451HW | 咨询 |
| Ruthenium Nanopowder (Ru, 99.95%, 20-30 nm) | 0441HW | 1g; |
| *Silicon Nanopowder (Si, 99%, 400 nm) | 0144HW | 100g; |
| *Silicon Nanopowder (Si, 99.9%, 100 nm) | 0149HW | 100g; |
| *Silicon Nanopowder (Si, > 97%, 50 nm) | 0145KE | 咨询 |
| *Silicon Nanopowder (Si, 99%, 30-50 nm) | 0147HW | 50g; |
| *Silicon Nanopowder (Si, 98+%, 30-50 nm) | 0141JS | 50g; 100g; 500g; 1kg; |
| Tin Nanopowder (Sn, 70 nm, w/PVP ) | 5522HW | 500g; |
| Tin Nanopowder (Sn, 99.9%, 60-80 nm) | 0501HW | 咨询 |
| *Tantalum Nanopowder (Ta, 99.9%, 40 nm) | 0225HW | 25g; |
| *Tantalum Nanopowder (Ta, 99.9%, 70 nm) | 0224HW | 25g; |
| *Titanium Nanopowder (Ti, 99%, 60-80 nm) | 0227HW | 25g / $361; |
| *Tungsten Powder (W, 99.5+%, 1-2 um) | 0747HW | 100g; |
| *Tungsten Nanopowder (W, 99.5%, 500 nm) | 0749HW | 1kg; |
| *Tungsten Nanopowder (W, 99.5%, <100 nm) | 0745HW | 100g; |
| *Zinc Nanopowder (Zn, 99%, 500 nm) | 0318HW | 1kg; |
| *Zinc Nanopowder (Zn, 99.5%, 130 nm) | 0303HW | 25g; |
| *Zinc Nanopowder (Zn, 99.9+%, 100 nm) | 0306JY | 25g; |
| *Zinc Nanopowder (Zn, 99.5%, 80 nm) | 0304HW | 25g; |
| *Aluminum Nitride Nanopowder (AlN, Amorphous, <0.5um, 99.9%) | 1004HW | 咨询 |
| Aluminum Nitride Nanopowder (AlN, 99.9 %, 0.5 um) | 1005HW | 咨询 |
| *Aluminum Nitride Nanopowder (AlN, 99.5 %, 70-80 nm) | 1002HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 500 μm) | 1175HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 50 μm) | 1177HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 40 μm) | 1179HW | 1kg; |
| Boron Carbide Powder (B4C, 98%, 20μm) | 1172HW | 1kg; |
| Boron Carbide Powder (B4C, 98%, 10μm) | 1169HW | 1kg; |
| Boron Carbide Powder (B4C, 99%, 5 μm) | 1165HW | 1kg; |
| Boron Carbide Powder (B4C, 99%, 2 um) | 1183HW | 1 kg; |
| Boron Carbide Powder (B4C, 99+%, 1-2 μm) | 1162HW | 咨询 |
| Boron Carbide Nanopowder (B4C, 99+%, 500 nm) | 1160HW | 500g; |
| Boron Carbide Nanopowder (B4C, 99%, 50nm) | 1161HY | 100g; |
| Boron Nitride Powder (BN, hexagonal, 99.8%, 0.6-1.2um) | 1182HW | 咨询 |
| Boron Nitride Nanopowder (BN, hexagonal, 99%, 137 nm) | 1180YL | 25g; |
| Boron Nitride Nanoplates (BN, 99.5+%, 100 nm) | 1183NJ | 100g; |
| Chromium Carbide Nanopowder (Cr3C2, 99.9%, <100 nm) | 0247HW | 500g; 1kg; |
| Hafnium Boride Nanopowder (HfB2, 99+%, 60 nm) | 1010JC | 100g; |
| Hafnium Carbide Nanopowder (HfC, 99+%, 200 nm) | 1005JC | 500g; |
| Hafnium Carbide Nanopowder (HfC, 99+%, 60 nm) | 1006JC | 100g; |
| Hafnium Carbide Nanopowder (HfC, 99%, 50nm) | 1022JC | kg; |
| Niobium Carbide Nanopowder (NbC, 99.9%, 500 nm) | 3860YM | 咨询 |
| Silicon Carbide Powder (SiC, 500 um, 99%, Hexagonal) | 4652HW | 1kg; ; |
| Silicon Carbide Powder (SiC, 50 um, 99%, Hexagonal) | 4654HW | 1kg; ; |
| Silicon Carbide Micron Powder (SiC, Beta, 40um, 99+%) | 4645HW | 1kg; ; |
| Silicon Carbide Powder (SiC, Beta, 20um, 99+%) | 4643HW | 1kg; ; |
| Silicon Carbide Powder (SiC, Beta, 10um, 99+%) | 4641HW | 1kg; ; |
| Silicon Carbide Micron Powder (SiC, Beta, 7um, 99+%) | 4639HW | 100g; 1kg; ; |
| Silicon Carbide Powder (SiC, beta, 99.8%, 5 μm) | 4637HW | 100g; ; |
| Silicon Carbide Powder (SiC, beta, 99+%, 2 μm) | 4635HW | 咨询 |
| Silicon Carbide Powder (SiC, alpha, 99.9%, 2um) | 4627HY | 1kg; |
| Silicon Carbide Powder (SiC, 500 nm, 99%, Cubic) | 4656HW | 1kg; ; |
| Silicon Carbide Nanopowder (SiC, beta, 99%, 80-100 nm) | Stock # 4629HW | 100g; |
| Silicon Carbide Nanopowder (SiC, alpha, 99.9%, 55 nm) | 4625HY | 100g; |
| Silicon Carbide Nanopowder (SiC, beta, 97.5%, 45-55 nm) | 4620KE | 200g; |
| Silicon Carbide Nanopowder (SiC, alpha, 99.9%, 30 nm) | 4626HY | 100 g; 150 g; |
| Silicon Carbide Nanowhisker (beta, SiC, 99+%) | 4622HW | 25g; |
| Silicon Nitride Nanopowder (Si3N4, amorphous, 98.5+%, 15-30 nm) | 4750KE | 100g; |
| Titanium Boride Powder (TiB2, 2-12 μm ) | 5180HW | 100g |
| *Titanium Carbide Powder (TiC, 1 micron, 99%) | 5218YL | 500g; |
| *Titanium Carbide Nanoparticles (TiC, 100-200nm, 99+%) | 5217HW | 1kg; |
| Titanium Carbide (TiC, 99+%, 100 nm) | 5217JC | 100g; |
| *Titanium Carbide (TiC, 98+%, 80 nm) | 5220HT | 25g; 100g; |
| *Titanium Carbide Nanopowder (TiC, 97+%, 50 nm) | 5216KE | 100g; |
| *Titanium Nitride Powder (TiN, 99%, 1-3um) | 5352JC | 500g; 1kg; |
| *Titanium Nitride Nanoparticles (TiN, 99%, 100-200 nm) | 5357HW | 500g; |
| *Titanium Nitride Nanopowder (TiN, 97+%, 20 nm) | 5350KE | 100g; |
| Tungsten Carbide/Cobalt Nanopowder (8wt%Co/WC, < 200 nm, 99.5%) | 5561HW | 100g |
| Zirconium Carbide Nanopowder (ZrC, 99%, 8 um) | 5905KE | 100g; 250g; 500g; |
| *Zirconium Carbide Nanopowder (ZrC, 97%, 60 nm) | 5901KE | 100g; |
| *Zirconium Nitride Nanopowder (ZrN, 99.5%, 1-3um) | 6101JC | 500g; kg; |
| Zirconium Boride Nanopowder (ZrB2, 99%, 60 nm) | 5950JC | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9+%, 500 nm) | 1037HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99+%, 500 nm) | 1038HT | 100g; |
| Aluminum Oxide Nanopowder (alpha, aluminate coated, 98+%, 500 nm) | 1039HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9%, 200 nm) | Stock #:1040LQS | 100g |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9%, 150 nm) | 1005MR | 100g ; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9+%, 40-50 nm) | 1044HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha/theta, 99.99%, ~30nm ) | 1018WJ | 100g ; |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99+%, 500 nm) | 1045HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99.97%, 20-30 nm) | 1020MR | 100g; 500g; 1kg; |
| Aluminum Oxide Nanopowder (gamma, 99.5%, 50 nm) | 1007XX | 咨询 |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99.99%, 10 nm) | 1043HT | 100g; |
| Aluminum oxide nanopowder, (γ-phase) APS 20-30 nm, 99.95+% | 0125HW | 咨询 |
| Aluminum Oxide Nanopowder ( 99.99%, 30 nm ) for Lithium Batteries | 1016WJ | 咨询 |
| Aluminum Hydroxide Nanopowder (99.5 %, 50 nm) | 1040WJ | 咨询 |
| Boron Oxide Nanopowder (B2O3, 98%, 40-80 nm) | 1185DF | 咨询 |
| Boron Oxide Nanopowder (B2O3, 99%, 40-80 nm) | 1186DF | 1kg; |
| Bismuth Oxide Nanopowder (Bi2O3 , 99.9%, 100 nm) | 1171HT | kg; |
| Cerium Oxide, (CeO2, 99.99%, 200 nm) | 1445MG | 100g; |
| Cerium Oxide Nanopowder (CeO2, 99%, 50-100 nm) | 1408HW | 100g; |
| Cerium Oxide (CeO2, 99.99%, 20-30 nm) | 1444ZQ | 100g; |
| Cerium Oxide Nanopowder (CeO2, 99.9%, 15-30 nm) | 1406RE | 100g; |
| Cobalt(II,III) Oxide Nanopowder (Co3O4, 99%, 50-80 nm) | 1720HT | 咨询 |
| Chromium Oxide Powder (Cr2O3, 99.8%, 1 um) | 1920FY | 25g; 1kg; |
| Chromium Oxide Powder (Cr2O3, 99.9%, 100 nm) | 1925FY | 100g; 1kg; |
| Chromium Oxide Nanopowder (Cr2O3, 99+%, 60 nm) | 1910FY | 25g; |
| Copper(II) Oxide Nanopowder (CuO, 99+%, 30-50 nm) | 2110FY | 咨询 |
| Copper(I) Oxide Nanopowder (Cu2O, 99%, 30-50 nm) | 2113HW | 25g; 100g; 500g; 1kg; |
| Dysprosium Oxide Nanopowder (Dy2O3, 99.9%, 55 nm) | 2252YS | 25g; |
| Dysprosium Oxide Nanopowder (Dy2O3, 99.9%, 30-70 nm) | 2253ZQ | 25g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 43 nm) | 2310ZQ | 65g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 41-53 nm) | 2350YS | 25g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 20-30 nm) | 2330RE | 25g ; |
| Europium Oxide Nanopowder (Eu2O3, 99.995%, 58 nm) | 2410ZQ | 5g; |
| Europium Oxide Nanopowder (Eu2O3, 99.99%, 45-58 nm) | 2450YS | 5g; |
| Europium Oxide Nanopowder (Eu2O3, 99.99%, 30-50 nm) | 2411RE | 5g; |
| Iron(III) Oxide Nanopowder (Fe2O3, gamma, 99.98%, 50 nm) | 2527YM | 1kg |
| Iron(III) Oxide Nanopowder (Fe2O3, alpha, 99%, 30-50 nm) | 2520ZH | 25g; 100g; |
| Iron(III) Oxide Nanopowder (Fe2O3, alpha, 99%, 30 nm) | 2525WJ | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, 100-200 nm) | 2653HW | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 97%, 50-100 nm) | 2650TS | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, SSA: 9-14 m2/g, 50-100 nm) | 2655HW | 100g; 500g; 1kg; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, 30 nm) | 2651WJ | 100g; |
| Iron Oxide Nanopowder (Fe3O4, PVP coated, 99+%, 20-30 nm) | 2657HW | 100g; 1kg; |
| Gadolinium Oxide Nanopowder (Gd2O3, 99.9+%, 20-80 nm) | 2680ZQ | 咨询 |
| Gadolinium Oxide Nanopowder (Gd2O3, 99.9%, 15-30 nm) | 2681RE | 咨询 |
| Hafnium Oxide Powder (HfO2, 99.99%, 48um) | 1045HW | 咨询 |
| Hafnium Oxide Powder (HfO2, 99%, 45um) | 1042HW | 咨询 |
| Indium Oxide Nanopowder (In2O3, 99.99%, 100-200 nm) | 2711TN | 咨询 |
| Indium Hydroxide Nanopowder (In(OH)3, 99.99%, 20-70 nm) | 2810TN | 咨询 |
| Lanthanum Oxide Nanopowder (La2O3, 99%, 50 nm) | 2922RE | 咨询 |
| Lanthanum Oxide Nanopowder (La2O3, 99.99%, 15-30 nm) | 2920RE | 咨询 |
| Magnesium Oxide Nanopowder (MgO, 99+%, 40-60 nm) | 3305HT | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 40nm) | 3912RE | 1kg; |
| Magnesium Oxide Nanopowder (MgO, 99+%, 40 nm) | 3304HT | 咨询 |
| Magnesium Hydroxide Nanopowder (Mg(OH)2, 98+%, 100 nm) | 3321HT | 咨询 |
| Molybdenum(VI) Oxide Nanopowder (MoO3 , 99.5%, 100 nm) | 3851XW | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9+%, 83 nm) | 3910ZQ | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 49-64 nm) | 3950YS | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 40nm) | 3912RE | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 15-30 nm) | 3911RE | 25g; |
| Nickel Oxide Nanopowder (Ni2O3, 99.9%, 20-30 nm) | 4216HW | 100g; |
| Praseodymium Oxide Nanopowder (Pr6O11, 99.9%, 15-30 nm) | 4451RE | 25g; |
| Antimony Oxide Nanoparticles (Sb2O3, 99.99%, 20-30nm) | 6850HW | 咨询 |
| Silicon Oxide Powder (SiO2 , quartz, 99.99%, 1-3.5 μm) | 4856WG | 咨询 |
| Silicon Oxide Powder (SiO2 , quartz, 99.998%, 1-3.5um) | 4855WG | 咨询 |
| Silicon Oxide Nanopowder (SiO2 , 99+%, 20 nm) | 4830HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4831HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4832HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4833HT | 咨询 |
| Samarium Oxide Nanopowder (Sm2O3, 99.9%, 42-55 nm) | 4950YS | 咨询 |
| Samarium Oxide Nanopowder (Sm2O3, 99.9%, 15-30 nm) | 4951RE | 咨询 |
| Titanium Oxide Nanopowder (TiO2, amorphous/anatase, 99+%, 5 nm) | 5416HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 99%, 10-30 nm) | 5420HT | 咨询 |
| Titanium Oxide Nanopowder(TiO2, anatase, 99%,15 nm) | 5430MR | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 99+%, 10 nm) | 5417HT | 咨询 |
| Titanium Oxide Nanopowder (tungsten oxide doped, TiO2/WO3, anatase, 10 nm) | 5418HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 5 nm) | 5421ZH | 咨询 |
| Titanium Oxide Nanotubes (TiO2, anatase, 99%, 10-15 nm) | 5432HW | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase/rutile, 99+%, 20 nm) | 5419HT | 咨询 |
| Titanium oxide, silica & alumina coated (anatase/rutile, 30 nm) | 5426HT | 咨询 |
| Titanium oxide (silica, alumina & stearic acid coated, anatase/rutile, 30 nm) | 5427HT | 咨询 |
| Titanium Oxide Nanopowder (silica, alumina & silicone oil coated, anatase/rutile, 30 nm) | 5428HT | 咨询 |
| Titanium oxide, silica coated (anatase/rutile, 20 nm) | 5422HT | 咨询 |
| Titanium oxide, silica & alumina coated (anatase/rutile, 20 nm) | 5423HT | 咨询 |
| Titanium oxide, silica & stearic acid coated (anatase/rutile, 20 nm) | 5424HT | 咨询 |
| Titanium oxide, silica & silicone oil coated (anatase/rutile, 20 nm) | 5425HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 500 nm) | 5429HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 150 nm) | 5430HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 100 nm) | 5431HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.8%, 60 nm) | 5486WJ | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.8%, 20-50 nm) | 5484WJ | 咨询 |
| Titanium Oxide (TiO2, rutile, coated with silicon oxide, 20 nm) | 0302HT | 咨询 |
| Titanium Oxide (TiO2, rutile, coated with silicon oxide, 20 nm) | 0301HT | 咨询 |
| Vanadium Oxide Nanopowder (VO2, 99.9+%, 100 - 200 nm) | 5495HW | 咨询 |
| 1.5% Tungsten-doped Vanadium Oxide Nanopowder (W-doped VO2, 99.9+%, 30 - 50 nm) | 5499HW | 咨询 |
| 1% Tungsten-doped Vanadium Oxide Nanopowder (W-doped VO2, 99.9+%, 30 - 50 nm) | 5498HW | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99.5%, 60-120 nm) | 5508YL | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99.9+%, 40-50 nm) | 5506BD | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99+%, 30-70 nm) | 5505YL | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99+%, 30-70 nm, PVP-coated) | 5506YL | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.995%, 50-70 nm) | 5610ZQ | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.99%, 20-40 nm) | 5611RE | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.9%, 32-36 nm) | 5650YS | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.995%, 20-40 nm) | 5611ZQ | 咨询 |
| Ytterbium Oxide Nanopowder (Yb2O3, 10-80 nm, 99.9%) | 5671RE | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99+%, 800 nm) | 5816HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99%, 30 nm) | 5811HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, hydrophilic & lipophilic) | 5812HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, silicone oil coated) | 5814HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, stearic acid coated) | 5815HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99%, 20 nm) | 5810HT | 咨询 |
| Zirconium Oxide Nanopowder (ZrO2, 99+%, 50 nm) | 5936HT | 咨询 |
| Zirconium Oxide Nanopowder (ZrO2, 99.5+%, 20 nm) | 5931HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/3 mol% Y2O3, 99.5+%, 15-50 nm) | 5932HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/5 mol% Y2O3, 99.5+%, 15-50 nm) | 5934HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/8 mol% Y2O3, 99.5+%, 15-50 nm) | 5933HT | 咨询 |
| Zirconia Nanopowder, Calcia Doped (ZrO2/8 mol%CaO, 99.9%, 20-30 nm) | 5934ZS | 咨询 |
| Barium Titanate Nanopowder (BaTiO3 , 99.9%, 400 nm) | 1146DY | 100g; |
| Barium Titanate Nanopowder (BaTiO3 , 99.9%, 300 nm) | 1144DY | 咨询 |
| Barium Titanate Nanopowder (BaTiO3 , 99.5%, 100-200 nm) | 1148DY | 咨询 |
| Cobalt Iron Oxides Nanopowder (CoFe2O4, 98%, 35-55 nm) | 1510FY | 25g ; 100g; |
| Cobalt-Zinc Iron Oxide Nanopowder (Co0.5Zn0.5Fe2O4, 99.5%, 30-50 nm) | 1515FY | 25g ; 100g; |
| Indium Tin Oxide Nanopowder (In2O3:SnO2 = 90wt%:10wt%, 99.99%, 20-70 nm) | 2730TN | 5g; 25g; |
| Indium Tin Oxide Nanopowder (In2O3:SnO2 = 95 wt%:5 wt%, 99.99%, 30-50 nm) | 2731BY | 5g; 25g; |
| Nickel-Zinc Iron Oxide Nanopowder (Ni0.5Zn0.5Fe2O4, 98.5%, 10-30 nm) | 4115FY | 100g; 500g; |
| *Ni80Fe17Mo3 permalloy nanopowder (99+%, 70 nm) | 9288HW | 100g; |
| Yttrium Aluminate w/Nd doped (Y2.98Nd0.02Al5O12, Nd-YAG, 99.5%, 40 nm) | 5571FY | 25g; 100g; |
| Zinc Iron Oxide Nanopowder (ZnFe2O4, 98.5%, 40 nm) | 5710FY | 100g; |
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

艾美捷科技代理Berry & Associates全系列修饰核苷酸等
美国 Berry & Associates 公司成立于1989年,提供近200种亚磷酰胺和核苷酸合成用固相交联单体,以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。
Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.







Berry & Associates的主要产品包括:
| 产品名称 | 产品编号 | 纯度 | 规格 |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2'-3'-Dideoxyguanosine | PR 3505 | ≥95% | 25 mg; 100 mg |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 2',3'-Dideoxyuridine | PY 7278 | ≥97% | 100 mg; 500 mg |
| 2',3'-Didehydro-2',3'-dideoxyuridine | PY 7279 | ≥97% | 25 mg; 100 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| 2-Amino-2'-deoxyadenosine | PR 3060 | ≥97% | 1 g; 5 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine | PR 3080 | ≥95% | 100 mg; 1 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-isobutyryl-2'-deoxyadenosine | PR 3130 | ≥95% | 100 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3670 | ≥95% | 100 mg; 1 g |
| 2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine | PR 3070 | ≥97% | 25 mg; 100 mg |
| 2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine | PR 3160 | ≥97% | 100 mg; 250 mg |
| 2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate | PR 3180 | ≥97% | 25 mg; 100 mg |
| 2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3680 | ≥97% | 100 mg; 1 g |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | PR 3006 | ≥95% | 25 mg; 100 mg |
| 8-Amino-2'-deoxyadenosine | PR 3115 | ≥97% | 10 mg; 100 mg |
| N6-(6-Aminohexyl)-2'-deoxyadenosine | PR 3120 | ≥90% | 100 mg; 1 g |
| 8-Azido-2'-deoxyadenosine | PR 3125 | ≥97% | 10 mg; 100 mg |
| N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | PR 3230 | ≥95% | 50 mg; 250 mg |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | PR 3260 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| 8-Benzyloxy-2'-deoxyadenosine | PR 3280 | ≥97% | 100 mg; 1 g |
| 8-Bromo-2'-deoxyadenosine | PR 3290 | ≥90% | 2 g; 10 g |
| 8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3320 | ≥95% | 100 mg; 1 g |
| 8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3340 | ≥97% | 0g (discontinued); |
| 2'-Deoxyadenosine Monohydrate | PR 3445 | ≥97% | 25 g; 100 g |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2-Fluoro-2'-deoxyadenosine | PR 3496 | ≥97% | 25 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| N6-Methyl-2'-deoxyadenosine | PR 3740 | ≥97% | 100 mg; 1 g |
| 4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine | PRA 10012 | ≥95% | 10 mg; 50 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| 7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine | PRA 10032 | ≥95% | 10 mg; 50 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 8-Allyloxy-2'-deoxyguanosine | PR 3010 | ≥90% | 0Discontinued; |
| 8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3015 | ≥90% | 1 g; 10 g |
| 8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3020 | ≥90% | 1 g; 10 g |
| 5'-Azido-5'-deoxyguanosine | PR 3225 | ≥90% | 5 mg; 10 mg |
| 8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3285 | ≥90% | 1 g; 10 g |
| 8-Bromo-2'-deoxyguanosine | PR 3300 | ≥90% | 1 g; 5 g |
| 8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine | PR 3310 | ≥97% | 500 mg; 1 g |
| 8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3330 | ≥90% | 250 mg; 1 g |
| 5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine | PR 3335 | ≥95% | 100 mg; 1 g |
| 2'-Deoxyguanosine monohydrate | PR 3452 | ≥97% | 10 g; 100 g |
| α-2'-Deoxyguanosine | PR 3455 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine | PR 3600 | ≥97% | 100 mg; 1 g |
| 3',5'-Di-O-acetyl-2'-deoxyguanosine | PR 3605 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine | PR 3630 | ≥97% | 100 mg; 1 g |
| N2-Ethyl-2'-deoxyguanosine | PR 3700 | ≥95% | 25 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| N2-Isobutyl-2'-deoxyguanosine | PR 3745 | ≥97% | 10 mg; 100 mg |
| N1-Methyl-2'-deoxyguanosine | PR 3748 | ≥97% | 25 mg; 1 g |
| N2-Methyl-2'-deoxyguanosine | PR 3750 | ≥97% | 25 mg; 100 mg |
| O6-Methyl-2'-deoxyguanosine | PR 3755 | ≥90% | 5 mg; 25 mg |
| 6-Thio-2'-deoxyguanosine | PR 3845 | ≥97% | 10 mg; 100 mg |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 2'-O-Methyladenosine | PR 3734 | ≥97% | 1 g; |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-thiouridine | PY 7575 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-(methylithio)uridine | PY 7577 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine | PR 3000 | ≥97% | 25 mg; 250 mg |
| 3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine | PR 3200 | ≥90% | 50 mg; 250 mg |
| 3'-Azido-2',3'-dideoxyadenosine | PR 3210 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-2',3'-dideoxyguanosine | PR 3220 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| N6-Benzoyl-3'-deoxyadenosine | PR 3240 | ≥97% | 100 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | PR 3250 | ≥97% | 100 mg; 1 g |
| 3'-Deoxyadenosine | PR 3430 | ≥97% | 10 mg; 100 mg |
| 3'-Deoxyguanosine | PR 3460 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine | PR 3590 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-3'-deoxyguanosine | PR 3690 | ≥97% | 20 mg; 100 mg |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine | PY 7230 | ≥97% | 100 mg; |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3040 | ≥97% | 1 g; |
| 2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3045 | ≥95% | 1 g; |
| 2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine | PR 3050 | ≥95% | 5 g; 25 g |
| 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3370 | ≥97% | 100 mg; 1 g |
| 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3380 | ≥90% | 100 mg; 1 g |
| 6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine | PR 3390 | ≥97% | 0 g; |
| 6-Chloro-9-(β-D-ribofuranosyl)purine | PR 3400 | ≥97% | 5 g; 10 g |
| Adenosine | PR 3005 | ≥97% | 100 g; 1 kg |
| 8-Methyladenosine | PR 3007 | ≥95% | 25 mg; 100 mg |
| Vidarabine | PR 3008 | ≥97% | 1 g; 5 g |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| N1-Methyladenosine hydroiodide | PR 3032 | ≥95% | 100 mg; 1 g |
| 2-Methyladenosine | PR 3035 | ≥97% | 10 mg; 25 mg |
| 5'-Chloro-5'-deoxyadenosine | PR 3360 | ≥97% | 100 mg; 1 g |
| N6-Methyladenosine | PR 3732 | ≥97% | 100 mg; 1 g |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10000 | ≥97% | 100 mg; 1 g |
| 2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10005 | ≥97% | 500 mg; 1 g |
| 4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine | PRA 10006 | ≥90% | 25 mg; 100 mg |
| 8-Azaadenosine | PRA 10007 | ≥97% | 20 mg; |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | PRA 10008 | ≥95% | 10 mg; 100 mg |
| 4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine | PRA 10009 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | PRA 10010 | ≥97% | 100 mg; 1 g |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; 1 g |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | PRA 10020 | ≥97% | 100 mg; 1 g |
| 3-Deaza-2'-deoxyadenosine | PRA 10025 | ≥97% | 25 mg; 100 mg |
| 7-Deaza-2'-deoxyadenosine | PRA 10030 | ≥97% | 100 mg; 1 g |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 7-Deaza-2'-deoxyguanosine | PRA 10040 | ≥97% | 100 mg; 1 g |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 7-Deaza-2'-deoxyxanthosine | PRA 10050 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine | PRA 10055 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10100 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10110 | ≥97% | 100 mg; 1 g |
| Sangivamycin | PRA 10140 | ≥97% | 10 mg; 25 mg |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; 100 mg |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| dNaM | FC 8110 | ≥97% | 25 mg; 100 mg |
| 9-Deaza-2'-deoxyguanosine | PRA 10120 | ≥97% | 10 mg; 100 mg |
| 9-Deazaguanosine | PRA 10130 | ≥97% | 10 mg; 100 mg |
| 2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine | PYA 11000 | ≥97% | 10 mg; 25 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| 2'-Deoxypseudoisocytidine | PYA 11005 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudouridine | PYA 11010 | Purity: ≥97% | 25 mg; |
| 5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine | PYA 11035 | Purity: ≥97% | 50 mg; 100 mg |
| 1,3-Dimethyl-2'-deoxypseudouridine | PYA 11040 | ≥97% | 10 mg; 100 mg |
| 1,3-Dimethylpseudouridine | PYA 11050 | ≥97% | 10 mg; 50 mg |
| N1-Methylpseudouridine | PYA 11052 | ≥95% | 10 mg; 50 mg |
| N3-Methylpseudouridine | PYA 11054 | ≥97% | 10 mg; 25 mg |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Pseudoisocytidine hydrochloride | PYA 11060 | ≥97% | 10 mg; 100 mg |
| Pseudothymidine | PYA 11070 | ≥97% | 10 mg; 100 mg |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; 50 mg |
| 3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine | PR 3350 | ≥97% | 10 mg; |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-Deoxy-8,5'-cycloadenosine | PR 3440 | ≥97% | 10 mg; 100 mg |
| 2',5'-Dideoxy-8,5'-cycloadenosine | PR 3500 | ≥97% | 10 mg; |
| 2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine | PR 3730 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-8,5'-cycloadenosine | PR 3800 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-2'-deoxy-8,5'-cycloadenosine | PR 3810 | ≥97% | 10 mg; |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | PY 7054 | ≥97% | 25 mg; 100 mg |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 5-Bromo-2'-deoxycytidine | PY 7115 | ≥97% | 1 g; 10 g |
| Cytidine | PY 7215 | ≥97% | 50 g; 500 g |
| 2'-Deoxycytidine | PY 7216 | ≥97% | 10 g; 50 g |
| 2'-Deoxycytidine Hydrochloride | PY 7217 | ≥97% | 5 g; 50 g |
| 5'-Azido-2',5'-dideoxycytidine | PY 7219 | ≥97% | 25 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| N4-Ethyl-2'-deoxycytidine | PY 7245 | ≥97% | 100 mg; 250 mg |
| 5-Methyl-2'-deoxyisocytidine | PY 7255 | ≥95% | 500 mg; 1 g |
| 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7270 | ≥97% | 20 mg; 50 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7380 | ≥97% | 50 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine | PY 7410 | ≥97% | 100 mg; |
| 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one | PY 7540 | ≥95% | 250 mg; 500 mg |
| Cytidin-5-yl-methanesulfonate sodium salt hydrate | PY 7586 | ≥95% | 50 mg; 100 mg |
| 5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine | PY 7587 | ≥97% | 10 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxycytidine | PY 7588 | ≥97% | 50 mg; 100 mg |
| 5-Formyl-2'-deoxycytidine | PY 7589 | ≥97% | 5 mg; 10 mg |
| 5-Carboethoxy-2'-deoxycytidine | PY 7592 | ≥95% | 25 mg; 100 mg |
| 2'-Deoxycytidine-5-carboxylic acid, sodium salt | PY 7593 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxymethylcytidine | PY 7596 | ≥97% | 50 mg; 100 mg |
| Cytidine-5-carboxylic acid, sodium salt | PY 7598 | ≥97% | 10 mg; 50 mg |
| 5-Formylcytidine | PY 7599 | ≥97% | 5 mg; 10 mg |
| 5-Iodo-2'-deoxycytidine | PY 7607 | ≥97% | 2 g; 10 g |
| 5-Iodocytidine | PY 7609 | ≥97% | 5 g; |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Methyl-2'-deoxycytidine Hydrochloride | PY 7635 | ≥97% | 0.25 g; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methylcytidine | PY 7637 | ≥97% | 1 g; 5 g |
| N4-Methylcytidine | PY 7638 | ≥97% | 25 mg; 100 mg |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 2-Thiocytidine | PY 7721 | ≥97% | 10 mg; 100 mg |
| 2-Thio-2'-deoxycytidine | PY 7723 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| 8-Hydroxyguanosine | PR 3795 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 5-Aza-2'-deoxycytidine | PY 7105 | ≥95% | 25 mg; 100 mg |
| 5,6-Dihydro-5-aza-2'-deoxycytidine | PY 7106 | ≥97% | 25 mg; 100 mg |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| Nap-dU | PY 7735 | ≥97% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 8-18O-Hydroxyguanosine | IOPR 3795 | ≥95% | 2 mg; 5 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| N2-Dimethylguanosine | PR 3702 | ≥97% | 10 mg; 100 mg |
| Guanosine | PR 3703 | ≥97% | 100 g; 500 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| O6-Methylguanosine | PR 3757 | ≥97% | 25 mg; 100 mg |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 8-Bromoguanosine | PR 3796 | ≥97% | 0 g; |
| 8-Benzyloxyguanosine | PR 3797 | ≥95% | 100 mg; 1 g |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 2'-Deoxy-4-desmethylwyosine | PR 3450 | ≥95% | 100 mg; 500 mg |
| 2'-Deoxyinosine | PR 3463 | ≥97% | 10 g; 100 g |
| 5'-Azido-2',5'-dideoxyinosine | PR 3464 | ≥97% | 5 mg; 25 mg |
| 3',5'-Di-O-acetyl-2'-deoxyinosine | PR 3480 | ≥97% | 1 g; |
| 3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine | PR 3490 | ≥90% | 1 g; |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| 5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | PR 3660 | ≥97% | 100 mg; 1 g |
| Inosine | PR 3725 | ≥97% | 100 g; 500 g |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| O6-Phenyl-2'-deoxyinosine | PR 3840 | ≥97% | 100 mg; 1 g |
| 2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3842 | ≥97% | 25 mg; |
| 5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3843 | ≥90% | 25 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | PR 3510 | ≥90% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3520 | ≥95% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3530 | ≥90% | 100 mg; 1 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| d5SICS | FC 8120 | ≥97% | 25 mg; 100 mg |
| AICA Riboside (AICAR) | MN 20001 | ≥97% | 0 g (DISCONTINUED); |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine | PR 3692 | ≥95% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| tC Nucleoside | PYA 11110 | ≥97% | 50 mg; 100 mg |
| tCnitro Nucleoside | PYA 11115 | ≥95% | 5 mg; 25 mg |
| 2'-Deoxynebularine | PR 3470 | Purity: ≥97% | 100 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole | PYA 11020 | ≥97% | 50 mg; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole | PYA 11030 | ≥95% | 100 mg; |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; |
| 5'-Amino-5'-deoxythymidine | PY 7030 | ≥97% | 25 mg; 50 mg |
| O2,5'-Anhydrothymidine | PY 7060 | ≥95% | 500 mg; 1 g |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 5'-Azido-5'-deoxythymidine | PY 7070 | ≥97% | 25 mg; 100 mg |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7120 | ≥97% | 1 g; |
| 3'-O-(t-Butyldimethylsilyl)thymidine | PY 7130 | ≥95% | 500 mg; 1 g |
| 5'-O-(t-Butyldimethylsilyl)thymidine | PY 7140 | ≥97% | 5 g; 10 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)thymidine | PY 7150 | ≥97% | 1 g; 5 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine | PY 7160 | ≥95% | 100 mg; 500 mg |
| S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine | PY 7200 | ≥95% | 10 mg; 100 mg |
| S4-(2-Cyanoethyl)-4-thiothymidine | PY 7210 | ≥95% | 10 mg; 100 mg |
| 5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7250 | ≥97% | 1 g; |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one | PY 7315 | ≥90% | 1 g; 10 g |
| 2',3'-Didehydro-3'-deoxythymidine | PY 7328 | ≥95% | 10 mg; 100 mg |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| 5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine | PY 7510 | ≥97% | 50 mg; 100 mg |
| 2-O-Ethylthymidine | PY 7561 | ≥97% | 500 mg; 1 g |
| 5'-Iodo-5'-deoxythymidine | PY 7610 | ≥97% | 250 mg; 1 g |
| 5'-O-Methylthymidine | PY 7680 | ≥95% | 50 mg; 100 mg |
| 2-Thiothymidine | PY 7725 | ≥95% | 20 mg; 100 mg |
| Thymidine | PY 7727 | ≥97% | 25 g; 250 g |
| 5'-O-(p-Toluenesulfonyl)thymidine | PY 7740 | ≥97% | 5 g; |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5'-Trifluoroacetamido-5'-deoxythymidine | PY 7750 | ≥97% | 50 mg; |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 6-Azathymidine | PYA 11058 | ≥95% | 25 mg; 100 mg |
| NPOM-Caged-dT CEP | BA 0317 | ≥95% | 100 µmol; 0.25 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 5-Ethynyl uridine CEP | BA 0353 | ≥90% | 100 µmol; 0.25 g |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 5-(Furan-2-yl)-2'-deoxyuridine | PY 7053 | ≥97% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one | PY 7055 | ≥97% | 20 mg; 100 mg |
| 5-Bromo-2'-deoxyuridine | PY 7117 | ≥97% | 10 g; 25 g |
| 5-Bromouridine | PY 7118 | ≥95% | 5 g; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carbomethoxyvinyl)uridine | PY 7172 | ≥97% | 25 mg; 250 mg |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)uridine | PY 7185 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine | PY 7212 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 2'-Deoxyuridine | PY 7275 | ≥97% | 25 g; 100 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine | PY 7280 | ≥95% | 100 mg; 500 mg |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7310 | ≥97% | 20 mg; 50 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine | PY 7450 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5-Methoxymethyl-2'-deoxyuridine | PY 7465 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-Ethynyl-2'-deoxyuridine | PY 7562 | ≥97% | 25 mg; 100 mg |
| 5-Ethynyl uridine | PY 7563 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-deoxyuridine | PY 7565 | ≥97% | 100 mg; 1 g |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7580 | ≥97% | 25 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7590 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Acetoxymethyl-2'-deoxyuridine | PY 7604 | ≥97% | 25 mg; 100 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 2'-Fluoro-5'-iodo deoxyuridine | PY 7612 | ≥95% | 100 mg; |
| 5-Iodo-2'-deoxyuridine | PY 7615 | ≥97% | 10 g; 25 g |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 5-Iodouridine | PY 7632 | ≥95% | 5 g; 25 g |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 3-Methyluridine | PY 7694 | ≥97% | 25 mg; 100 mg |
| 5-Methyluridine | PY 7695 | ≥97% | 200 mg; 1 g |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 5-(Propargyloxy)-2'-deoxyuridine | PY 7712 | ≥95% | 10 mg; 100 mg |
| Zebularine | PY 7715 | ≥97% | 10 mg; 25 mg |
| 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine | PY 7720 | ≥90% | 500 mg; 1 g |
| 2-Thiouridine | PY 7724 | ≥97% | 25 mg; 100 mg |
| 5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine | PY 7730 | ≥97% | 1 g; 5 g |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine | PY 7758 | ≥97% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| 5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine | PY 7775 | ≥97% | 100 mg; 1 g |
| Uridine | PY 7780 | ≥97% | 100 g; 500 g |
| 2'3'-O-Isopropylidene uridine | PY 7781 | ≥97% | 5 g; 25 g |
| 5-Hydroxymethyl uridine | PY 7782 | ≥97% | 50 mg; 100 mg |
| 5-Methoxyuridine | PY 7783 | ≥97% | 10 mg; 50 mg |
| 6-Aza-2'-deoxyuridine | PYA 11057 | ≥95% | 50 mg; 100 mg |
" data-original="http://atlas.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸

艾美捷科技代理Roboscreen 品牌。
Roboscreen Diagnostics公司,正式名称为ROBOSCREEN GmbH,是一家专注于研发和生产高质量诊断工具的公司,在qPCR应用开发、单克隆抗体的产生以及它们在免疫化学测试构建中的应用方面具有高水平的专业知识。
ROBOSCREEN GmbH提供的产品和服务涵盖了病毒病原体检测、核酸提取以及神经退行性疾病诊断等多个领域,具体包括:
(1)病毒性病原体诊断产品:针对肝炎C、B和DELTA等病毒的诊断测试,以及用于HSV1/2、CMV、EBV和VZV等疱疹病毒的检测和定量的RealLine Kits。
(2)核酸提取产品:提供高效的核酸提取解决方案,如Rapid INSTANT Virus RNA/DNA Kit - FX,该产品支持仅需35分钟的自动化核酸提取,适用于96个样本的批量处理。
(3)神经退行性疾病诊断产品:包括用于阿尔茨海默病、帕金森病、克雅氏病和疯牛病等的诊断工具,如酶联免疫吸附HTAU total ELISA等。
(4)此外,ROBOSCREEN GmbH还提供科学研究产品,用于在科学项目范围内识别和测量生物标志物。
ROBOSCREEN GmbH技术优势包括:
创新能力:ROBOSCREEN GmbH以其创新能力而著称,不断开发新的诊断工具和方法,以应对不断变化的疾病挑战。
高质量产品:公司的产品以其高灵敏度、高特异性和操作简便而受到认可,支持快速、准确的诊断,有助于提高疾病监测和治疗的效率。
质量控制:ROBOSCREEN GmbH的生产流程遵循严格的质量控制标准,确保产品的可靠性和一致性。

艾美捷科技特约代理Ellastin Products Company公司产品。Ellastin Products Company成立30余年,产品不多但是获得了许多客户的青睐,这些客户遍布于高校,研究机构,医学中心等。
Elastin Products Company, Inc. has been manufacturing quality biochemicals for 30 years. Providing research products to many pharmaceutical companies, universities, and researchers. Our quality in products have been estabilished for many years through the publishing of papers using EPC as the source. Thank you for the continued interest in our products.
ELASTIN PRODUCTS COMPANY的主要产品包括:
Polyclonal Antibody to Human Lung Tryptase IgG purified
Polyclonal Antibody to Proteinase 3-IgG purified
Polyclonal Antibody to Porcine Pancreas Elastase
Polyclonal Antibody to Human Myeloperoxidase
Monoclonal Antibody to Bovine Ligamentum Nuchae Elastin
Human Sputum Leucocyte Myeloperoxidase
Elastin Soluble
Lipase
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://atlas.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Elastin Products Company"> Elastin Products Company地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18995651644
传真:13212737804
邮箱:sales@amyjet.com
0.3948